$81.7 Million is the total value of Kazazian Asset Management, LLC's 70 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | New | VERTEX PHARMACEUTICALS INC | $887,000 | – | 5,837 | +100.0% | 1.09% | – |
| CMG | New | CHIPOTLE MEXICAN GRILL INC | $800,000 | – | 2,600 | +100.0% | 0.98% | – |
| TSRO | New | TESARO INC | $677,000 | – | 5,246 | +100.0% | 0.83% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $661,000 | – | 12,241 | +100.0% | 0.81% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $543,000 | – | 17,492 | +100.0% | 0.66% | – |
| ZGNX | New | ZOGENIX INC | $511,000 | – | 14,582 | +100.0% | 0.62% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $503,000 | – | 8,666 | +100.0% | 0.62% | – |
| DOFSQ | New | DIAMOND OFFSHORE DRILLING IN | $479,000 | – | 33,000 | +100.0% | 0.59% | – |
| CXO | New | CONCHO RES INC | $435,000 | – | 3,300 | +100.0% | 0.53% | – |
| COG | New | CABOT OIL & GAS CORP | $425,000 | – | 15,900 | +100.0% | 0.52% | – |
| PTEN | New | PATTERSON UTI ENERGY INC | $419,000 | – | 20,000 | +100.0% | 0.51% | – |
| NBL | New | NOBLE ENERGY INC | $408,000 | – | 14,400 | +100.0% | 0.50% | – |
| APA | New | APACHE CORP | $389,000 | – | 8,500 | +100.0% | 0.48% | – |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $382,000 | – | 10,992 | +100.0% | 0.47% | – |
| IMGN | New | IMMUNOGEN INC | $357,000 | – | 46,644 | +100.0% | 0.44% | – |
| PXD | New | PIONEER NAT RES CO | $354,000 | – | 2,400 | +100.0% | 0.43% | – |
| PE | New | PARSLEY ENERGY INCcl a | $350,000 | – | 13,300 | +100.0% | 0.43% | – |
| BIVV | New | BIOBERATIV INC | $266,000 | – | 4,663 | +100.0% | 0.33% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $265,000 | – | 5,832 | +100.0% | 0.32% | – |
| YNDX | New | YANDEX N V | $221,000 | – | 6,693 | +100.0% | 0.27% | – |
| BTU | New | PEABODY ENERGY CORP NEW | $214,000 | – | 7,368 | +100.0% | 0.26% | – |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $197,000 | – | 5,247 | +100.0% | 0.24% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $144,000 | – | 11,686 | +100.0% | 0.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GENERAL MTRS CO | 20 | Q3 2019 | 9.4% |
| APPLE INC | 20 | Q3 2019 | 8.8% |
| CITIGROUP INC | 20 | Q3 2019 | 6.2% |
| ALIBABA GROUP HLDG LTD | 20 | Q3 2019 | 2.6% |
| EQUUS TOTAL RETURN INC | 20 | Q3 2019 | 0.1% |
| MECHEL PAO | 20 | Q3 2019 | 0.1% |
| GENERAL MOLY INC | 20 | Q3 2019 | 0.0% |
| GENERAL MTRS CO | 19 | Q2 2019 | 0.5% |
| SPDR S&P 500 ETF TR | 17 | Q3 2019 | 51.5% |
| BAIDU INC | 17 | Q3 2019 | 6.5% |
View Kazazian Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GEE Group Inc. | February 14, 2022 | 182,555 | 0.2% |
| Bonds.com Group, Inc. | July 10, 2013 | 28,571 | 10.5% |
View Kazazian Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2022-02-14 |
| SC 13G | 2021-04-29 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-15 |
View Kazazian Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.